The New Obesity Classification Based on Weight History is Not Proposed As a Guideline
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Pharmacotherapy for obesity: moving towards efficacy improvement.
Coutinho W, Halpern B Diabetol Metab Syndr. 2024; 16(1):6.
PMID: 38172940 PMC: 10763391. DOI: 10.1186/s13098-023-01233-4.
Halpern B, Mancini M, van de Sande-Lee S, Miranda P Arch Endocrinol Metab. 2023; 67(4):e230174.
PMID: 37585688 PMC: 10665066. DOI: 10.20945/2359-4292-2023-0174.
References
1.
Halpern B, Mancini M, de Melo M, Lamounier R, Moreira R, Carra M
. Proposal of an obesity classification based on weight history: an official document by the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society for the Study of Obesity and Metabolic Syndrome (ABESO). Arch Endocrinol Metab. 2022; 66(2):139-151.
PMC: 9832894.
DOI: 10.20945/2359-3997000000465.
View
2.
Le Roux C, Aroda V, Hemmingsson J, Cancino A, Christensen R, Pi-Sunyer X
. Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m²: A Post-hoc Analysis. Obes Facts. 2017; 10(6):531-544.
PMC: 5836203.
DOI: 10.1159/000478099.
View
3.
Candido F, Coelho O, Balbino K, Hermsdorff H
. Improving applicability of the new obesity classification based on weight history in severe obesity. Arch Endocrinol Metab. 2022; 66(6):934-935.
PMC: 10118762.
DOI: 10.20945/2359-3997000000572.
View
4.
Muller T, Bluher M, Tschop M, DiMarchi R
. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2021; 21(3):201-223.
PMC: 8609996.
DOI: 10.1038/s41573-021-00337-8.
View
5.
. Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study. Diabetes Care. 2022; .
PMC: 9174966.
DOI: 10.2337/dc21-1805.
View